2001
DOI: 10.1207/s15327752jpa7703_11
|View full text |Cite
|
Sign up to set email alerts
|

Adherence to Substance Abuse Treatment: Clinical Utility of Two MMPI-2 Scales

Abstract: In this study, we examined the ability of the MMPI-2 (Butcher, Dahlstrom, Graham, Tellegen, & Kaemmer, 1989) Addiction Acknowledgment scale (AAS; Weed, Butcher, McKenna, & Ben-Porath, 1992) and Negative Treatment Indicators scale (TRT; Butcher, Graham, Williams, & Ben-Porath, 1990) to predict adherence to and outcomes from substance abuse treatment. There was no evidence that the AAS was related to treatment adherence or outcome in our sample. However, results did reveal a significant positive relation between… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
11
0

Year Published

2004
2004
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(11 citation statements)
references
References 37 publications
0
11
0
Order By: Relevance
“…These include greater clinical severity (e.g., more complex clinical pictures, more comorbid diagnoses, poorer functioning, personality disorders; see Barrett et al, 2008, andSwift &Greenberg, 2012, for review), lower satisfaction with treatment and poorer patient-reported therapeutic alliance (Barrett et al, 2008;Kegel & Flückiger, 2014;Renk & Dinger, 2002;Shamir, Szor, & Melamed, 2010;Wnuk et al, 2013), and lower socioeconomic status and younger age (see Barrett et al, 2008;Swift & Greenberg, 2012 for review). Findings regarding sex, education level, race/ethnicity, and negative attitudes toward treatment have been equivocal (Anestis, Finn, Gottfried, Arbisi, & Joiner, 2015;Barrett et al, 2008;Chisholm, Crowther, & Ben-Porath, 1997;Gilmore, Lash, Foster, & Blosser, 2001;Munley & Busby, 1994;Swift & Greenberg, 2012). It is important to consider, however, that while useful and informative, these studies' findings cannot be directly applied to suicidal individuals because different clinical populations can vary significantly from one another.…”
Section: Journal Of Clinical Psychology Xxxx 2016mentioning
confidence: 99%
See 1 more Smart Citation
“…These include greater clinical severity (e.g., more complex clinical pictures, more comorbid diagnoses, poorer functioning, personality disorders; see Barrett et al, 2008, andSwift &Greenberg, 2012, for review), lower satisfaction with treatment and poorer patient-reported therapeutic alliance (Barrett et al, 2008;Kegel & Flückiger, 2014;Renk & Dinger, 2002;Shamir, Szor, & Melamed, 2010;Wnuk et al, 2013), and lower socioeconomic status and younger age (see Barrett et al, 2008;Swift & Greenberg, 2012 for review). Findings regarding sex, education level, race/ethnicity, and negative attitudes toward treatment have been equivocal (Anestis, Finn, Gottfried, Arbisi, & Joiner, 2015;Barrett et al, 2008;Chisholm, Crowther, & Ben-Porath, 1997;Gilmore, Lash, Foster, & Blosser, 2001;Munley & Busby, 1994;Swift & Greenberg, 2012). It is important to consider, however, that while useful and informative, these studies' findings cannot be directly applied to suicidal individuals because different clinical populations can vary significantly from one another.…”
Section: Journal Of Clinical Psychology Xxxx 2016mentioning
confidence: 99%
“…Findings regarding sex, education level, race/ethnicity, and negative attitudes toward treatment have been equivocal (Anestis, Finn, Gottfried, Arbisi, & Joiner, 2015;Barrett et al, 2008;Chisholm, Crowther, & Ben-Porath, 1997;Gilmore, Lash, Foster, & Blosser, 2001;Munley & Busby, 1994;Swift & Greenberg, 2012). It is important to consider, however, that while useful and informative, these studies' findings cannot be directly applied to suicidal individuals because different clinical populations can vary significantly from one another.…”
Section: Treatment Attrition Suicidal Individuals 89mentioning
confidence: 99%
“…These studies generally support the use of the MMPI-2 in predicting treatment outcome and provide a rationale for conceptualizing its use in Drug Court settings. Gilmore, Lash, Foster, and Blosser (2001) examined the Addiction Acknowledgement Scale (AAS) and Negative Treatment Indicators (TRT) scales in predicting completion of a 28-day residential drug treatment program. The researchers found the AAS had no predictive value in regards to treatment; however, the TRT scale showed a significant negative correlation with treatment completion.…”
mentioning
confidence: 99%
“…Findings with regard to these variables using standardized assessment instruments have been mixed. Whereas factors related to amenability have consistently demonstrated relationships to poor treatment outcome, research on treatment motivation has received more mixed results using both performance-based (e.g., Rorschach: Ackerman, Hilsenroth, Baity, & Blagys, 2000;Alpher, Perfetto, Henry, & Strupp, 1990;Hilsenroth, Handler, Toman, & Padawer, 1995;Nygren, 2004;Viglione, 1999) and self-report (e.g., Minnesota Multiphasic Personality Inventory [MMPI]: Chisholm, Crowther, & Ben-Porath, 1997;Craig & Olson, 2004;Geer, Becker, Gray, & Krauss, 2001;Gilmore, Lash, Foster, & Blosser, 2001;Hilsenroth et al, 1995;Minnix et al, 2005) methods. For example, although the MMPI-2 Negative Treatment Indicators scale was designed to evaluate problematic client beliefs about psychotherapy, including low motivation for change, it has been somewhat effective in predicting treatment problems in some studies (e.g., Gilmore et al, 2001) but ineffective in several others (e.g., Hilsenroth et al, 1995;Minnix et al, 2005).…”
mentioning
confidence: 99%